We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions
cover of episode DeekSeek Resists Bringing on Investors

DeekSeek Resists Bringing on Investors

2025/3/17
logo of podcast WSJ Tech News Briefing

WSJ Tech News Briefing

AI Deep Dive AI Chapters Transcript
People
R
Rebecca Fung
S
Stephen Rosenbush
Topics
Stephen Rosenbush: 我是华尔街日报企业科技部门的负责人。美国生物科学行业正在面临着来自联邦政府的资金削减的风险。这些削减主要源于特朗普政府的节约措施,导致大学用于资助研究的拨款被冻结。虽然法院已经阻止了这些削减,但这仍然给生物科学行业带来了不确定性,威胁到药物研发以及美国在该领域的领导地位。大学正在通过削减研究生招生、减少博士后招聘和教职岗位等方式来应对资金的不确定性。这些削减是政府更广泛努力的一部分,旨在缩减联邦政府规模、削减预算,并减少其在经济中的作用。虽然资金削减的绝对数额可能并不巨大,但其长期影响可能非常显著,这可能会损害美国的药物研发能力,并导致美国更多地依赖中国的药物产品。 Rebecca Fung: 我是华尔街日报的记者。DeepSeek是一家备受关注的中国人工智能公司,它开发了一款智能且成本低廉的AI聊天机器人。然而,DeepSeek的创始人梁文锋却对外部投资持谨慎态度。他担心外部投资者会干涉公司的决策,并且不愿接受政府资金,以免影响DeepSeek的全球发展目标。DeepSeek最初是一家名为High Flyer的量化基金,通过高额的管理费积累了大量资金,为其AI业务发展提供了资金支持。目前,许多风投、私募以及一些与政府相关的基金都希望投资DeepSeek,大型科技公司如腾讯和阿里巴巴也希望与DeepSeek合作,例如腾讯正在测试DeepSeek的技术,将其应用于微信等应用程序中。DeepSeek的聊天机器人因用户激增而面临计算能力不足的问题,并且受到来自世界各地监管机构的数据安全方面的压力。DeepSeek目前尚未将聊天机器人商业化,这阻碍了投资者投资的意愿,DeepSeek 未来是否会商业化仍未确定。

Deep Dive

Chapters
Federal funding cuts are creating uncertainty in the bioscience industry, potentially threatening drug development and US leadership in the field. Universities are adapting by cutting back on graduate admissions, hiring, and faculty positions. The long-term impact could be a decreased capacity for the US to produce drugs, potentially leading to increased reliance on other countries like China.
  • Federal funding cuts are impacting universities' research funding, particularly in drug development.
  • Universities are responding by reducing graduate admissions and hiring.
  • The long-term impact may include reduced US capacity for drug production and increased reliance on other countries for these products.

Shownotes Transcript

The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why DeepSeek) is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the bioscience) industry. Shara Tibken hosts.

Sign up for the WSJ's free Technology newsletter).

Learn more about your ad choices. Visit megaphone.fm/adchoices)